Literature DB >> 16741333

Primitive neuroectodermal tumor (PNET) as second malignancy after treatment of Hodgkin's disease.

A Khadwal1, G Biswas, B Arora, P A Kurkure, C Deshmukh, V Shetty.   

Abstract

Hodgkin's disease survivors are at an increased risk of developing second malignant neoplasms including secondary bone tumors. Common secondary bone tumors are osteogenic sarcoma and fibrosarcoma. Secondary primitive neuroectodermal tumor is extremely rare in this group. We present below, a rare case of secondary PNET in an 8-year-old child with Hodgkin's disease which developed unusually early outside the radiation portal and discuss potential factors responsible for its causation.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16741333     DOI： 10.1007/bf02758571

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN： 0019-5456            Impact factor:   1.967


  12 in total

1.  Risk of second primary cancers after Hodgkin's disease by type of treatment: analysis of 2846 patients in the British National Lymphoma Investigation.

Authors:  A J Swerdlow; A J Douglas; G V Hudson; B V Hudson; M H Bennett; K A MacLennan
Journal:  BMJ       Date:  1992-05-02

2.  Peripheral neuroectodermal tumor of the chest wall in a patient treated for Hodgkin's disease.

Authors:  R Delgado-Chávez; P Sobrevilla-Calvo; L Green-Schneewiss; E Reynoso-Gómez; L Quintanilla-Martínez
Journal:  Leuk Lymphoma       Date:  1995-05

3.  Germ-line p53 mutations predispose to a wide spectrum of early-onset cancers.

Authors:  K E Nichols; D Malkin; J E Garber; J F Fraumeni; F P Li
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2001-02       Impact factor: 4.254

4.  Long-term survival and competing causes of death in patients with early-stage Hodgkin's disease treated at age 50 or younger.

Authors:  Andrea K Ng; M Patricia Bernardo; Edie Weller; Kendall H Backstrand; Barbara Silver; Karen C Marcus; Nancy J Tarbell; Jonathan Friedberg; George P Canellos; Peter M Mauch
Journal:  J Clin Oncol       Date:  2002-04-15       Impact factor: 44.544

5.  Peripheral neuroectodermal tumor of the chest (Askin tumor) as secondary neoplasm after Hodgkin's disease: a case report.

Authors:  A P Anselmo; C Cartoni; A Pacchiarotti; E Pescarmona; A Cafolla; E Rendina; F Mandelli
Journal:  Ann Hematol       Date:  1994-06       Impact factor: 3.673

6.  Second malignant neoplasms among long-term survivors of Hodgkin's disease: a population-based evaluation over 25 years.

Authors:  Graça M Dores; Catherine Metayer; Rochelle E Curtis; Charles F Lynch; E Aileen Clarke; Bengt Glimelius; Hans Storm; Eero Pukkala; Flora E van Leeuwen; Eric J Holowaty; Michael Andersson; Tom Wiklund; Timo Joensuu; Mars B van't Veer; Marilyn Stovall; Mary Gospodarowicz; Lois B Travis
Journal:  J Clin Oncol       Date:  2002-08-15       Impact factor: 44.544

7.  Second malignant neoplasms in childhood acute lymphoblastic leukemia: primitive neuroectodermal tumor of the chest wall with germline p53 mutation as a second malignant neoplasm.

Authors:  Carlos R Suarez; Salvatore J Bertolone; Ashok B Raj; Susan Coventry
Journal:  Am J Hematol       Date:  2004-05       Impact factor: 10.047

8.  Bone sarcomas linked to radiotherapy and chemotherapy in children.

Authors:  M A Tucker; G J D'Angio; J D Boice; L C Strong; F P Li; M Stovall; B J Stone; D M Green; F Lombardi; W Newton
Journal:  N Engl J Med       Date:  1987-09-03       Impact factor: 91.245

9.  TP53, BRCA1, and BRCA2 tumor suppressor genes are not commonly mutated in survivors of Hodgkin's disease with second primary neoplasms.

Authors:  Kim E Nichols; John A Heath; Debra Friedman; Jaclyn A Biegel; Arupa Ganguly; Peter Mauch; Lisa Diller
Journal:  J Clin Oncol       Date:  2003-12-15       Impact factor: 44.544

10.  Radiotherapy, alkylating agents, and risk of bone cancer after childhood cancer.

Authors:  M M Hawkins; L M Wilson; H S Burton; M H Potok; D L Winter; H B Marsden; M A Stovall
Journal:  J Natl Cancer Inst       Date:  1996-03-06       Impact factor: 13.506
View more
  3 in total

1.  Squamous cell carcinoma of the oral cavity in nonsmoking women: a new and unusual complication of chemotherapy for recurrent ovarian cancer?

Authors:  Timothy L Cannon; Dominic W Lai; David Hirsch; Mark Delacure; Andrea Downey; Alexander R Kerr; Michael Bannan; Eleni Andreopoulou; Tamar Safra; Franco Muggia
Journal:  Oncologist       Date:  2012-05-23

2.  Ewing's Sarcoma as a Second Malignancy in Long-Term Survivors of Childhood Hematologic Malignancies.

Authors:  Fabian Wolpert; Michael A Grotzer; Felix Niggli; Dieter Zimmermann; Elisabeth Rushing; Beata Bode-Lesniewska
Journal:  Sarcoma       Date:  2016-07-25

Review 3.  Sarcoma as Second Cancer in a Childhood Cancer Survivor: Case Report, Large Population Analysis and Literature Review.

Authors:  Thinh H Nguyen; Monish Ram Makena; Siddhartha Yavvari; Maninder Kaur; Teresia Pham; Eduardo Urias; Narendra Panapitiya; Mohamad M Al-Rahawan
Journal:  Medicina (Kaunas)       Date:  2020-05-07       Impact factor: 2.430
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.